iShares iBonds Dec 2027 Term Corporate ETF

FRC's fair value estimate for iShares iBonds Dec 2027 Term Corporate ETF, and the rating behind it. IBDS last traded at $24.20; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for iShares iBonds Dec 2027 Term Corporate ETF. Starting points for iShares iBonds Dec 2027 Term Corporate ETF: beta 0.44 — an Asset Management - Bonds name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for iShares iBonds Dec 2027 Term Corporate ETF. iShares iBonds Dec 2027 Term Corporate ETF paid $1.04 per share over the last year — a 4.3% yield at the current $24.20 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for iShares iBonds Dec 2027 Term Corporate ETF. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for iShares iBonds Dec 2027 Term Corporate ETF. iShares iBonds Dec 2027 Term Corporate ETF has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

iShares iBonds Dec 2027 Term Corporate ETF valued side by side against its closest peers. iShares iBonds Dec 2027 Term Corporate ETF is measured against Asset Management - Bonds peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold iShares iBonds Dec 2027 Term Corporate ETF, and how their positions are changing. At a $3.81B market value, institutional positions materially move iShares iBonds Dec 2027 Term Corporate ETF's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by iShares iBonds Dec 2027 Term Corporate ETF executives and directors. Shares of iShares iBonds Dec 2027 Term Corporate ETF have traded between $23.89 and $24.52 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming iShares iBonds Dec 2027 Term Corporate ETF. iShares iBonds Dec 2027 Term Corporate ETF is a $3.81B Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming iShares iBonds Dec 2027 Term Corporate ETF. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for iShares iBonds Dec 2027 Term Corporate ETF. Coverage tracks iShares iBonds Dec 2027 Term Corporate ETF within Asset Management - Bonds (Financial Services). Press releases and market coverage, newest first.